[
  {
    "ts": null,
    "headline": "Baxter International Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Baxter International Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=a072e412e6d1db2f380aa7cb502aa42da7fc617f02b8bbc678ab739252ff912e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750180260,
      "headline": "Baxter International Inc. stock underperforms Tuesday when compared to competitors",
      "id": 135403778,
      "image": "",
      "related": "BAX",
      "source": "MarketWatch",
      "summary": "Baxter International Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=a072e412e6d1db2f380aa7cb502aa42da7fc617f02b8bbc678ab739252ff912e"
    }
  },
  {
    "ts": null,
    "headline": "UBS Affirms Neutral Rating on Baxter International (BAX)",
    "summary": "Baxter International Inc. (NYSE:BAX) is one of the 12 best healthcare stocks to buy now. On June 11, UBS reiterated a ‘Neutral’ rating on the stock and a $35 price target. The Neutral stance follows a meeting with the company’s Head of Investor Relations. According to UBS, the company has demonstrated momentum across its portfolio […]",
    "url": "https://finnhub.io/api/news?id=7d35b733ac8ff5ef2bbe9fa3e3f67699492308b1a0a7121f04001ef1b25d1c27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750141453,
      "headline": "UBS Affirms Neutral Rating on Baxter International (BAX)",
      "id": 135318469,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Baxter International Inc. (NYSE:BAX) is one of the 12 best healthcare stocks to buy now. On June 11, UBS reiterated a ‘Neutral’ rating on the stock and a $35 price target. The Neutral stance follows a meeting with the company’s Head of Investor Relations. According to UBS, the company has demonstrated momentum across its portfolio […]",
      "url": "https://finnhub.io/api/news?id=7d35b733ac8ff5ef2bbe9fa3e3f67699492308b1a0a7121f04001ef1b25d1c27"
    }
  }
]